ITGAM and myeloproliferative neoplasm: Among MPN entities, both CD11b+ and CD11b− NK cells were decreased as compared to healthy controls in PV and ET while PMF patients presented not only a reduced cytotoxic phenotype but also an imbalance towards an immature NK profile with a significant increase in CD11b− cells as well as CD11b−CD27+ NK cells.